US Patent No. 9,801,934


Patent No. 9,801,934
Issue Date October 31, 2017
Title Parenteral Norovirus Vaccine Formulations
Inventorship Charles Richardson, Bozeman, MT (US)
Thomas R. Foubert, Bozeman, MT (US)
Assignee TAKEDA VACCINES, INC., Cambridge, MA (US)

Claim of US Patent No. 9,801,934

1. A buffered composition comprising a first monovalent VLP derived from a first Norovirus genogroup and a second monovalent
VLP derived from a second Norovirus genogroup, wherein the first Norovirus genogroup is genogroup I and the second Norovirus
genogroup is genogroup II, wherein said buffer is selected from L-histidine and imidazole, and wherein the composition is
formulated as a liquid.